This exemption applies specifically to medications requiring temperature control
The preparations are made to USP , , and standards for sterility, potency, and consistency
However, as safety signals around NAION have emerged, a growing number of filings and investigations now involve vision loss claims , including: Sudden, severe vision changes or permanent vision loss while on a GLP-1 drug Diagnosed NAION or other optic nerve injuries temporally linked to starting or escalating the medication Allegations that manufacturers failed to timely investigate, disclose, and warn about the risk of NAION, even as case reports and safety data accumulated Some vision-loss cases may proceed within or alongside the existing MDL, while others may be filed in state courts or as individual federal actions, depending on the facts and strategy
If you need support, contact our clinic line at 877.581.2210
& El-Agamy, D
If your Mounjaro dose is unavailable and the shortage timeline is uncertain, switching to Ozempic keeps you on active GLP-1 treatment rather than going without
